Literature DB >> 33552635

Genetic Polymorphisms of Drug-Metabolizing Enzymes Involved in 6-Mercaptopurine-Induced Myelosuppression in Thai Pediatric Acute Lymphoblastic Leukemia Patients.

Kanyarat Khaeso1, Nontaya Nakkam1, Patcharee Komwilaisak2, Piyathida Wongmast2, Su-On Chainansamit3, Areerat Dornsena1, Sirimas Kanjanawart1, Suda Vannaprasaht1, Wichittra Tassaneeyakul1.   

Abstract

Genetic polymorphisms of thiopurine S-methyltransferase (TPMT) and nucleoside diphosphate-linked moiety X-type motif 15 ( NUDT15 ) genes have been proposed as key determinants of 6-mercaptopurine (6-MP)-induced myelosuppression in pediatric acute lymphoblastic leukemia (ALL). In the present study, genotypes of TPMT and NUDT15 were investigated in 178 Thai pediatric patients with ALL by the TaqMan SNP genotyping assay and DNA sequencing. The frequency of TPMT*3C was 0.034. Among NUDT15 variants, NUDT15*3 is the most common variant with the allele frequency of 0.073, whereas those of NUDT15*2 , NUDT15*5 , and NUDT15*6 variants were 0.022, 0.011, and 0.039. These data suggest that a high proportion of Thai pediatric ALL patients may be at risk of thiopurine-induced myelosuppression. Thieme. All rights reserved.

Entities:  

Keywords:  nucleoside diphosphate-linked moiety X-type motif 15; pediatric acute lymphoblastic leukemia; thiopurine methyltransferase

Year:  2020        PMID: 33552635      PMCID: PMC7853920          DOI: 10.1055/s-0040-1715818

Source DB:  PubMed          Journal:  J Pediatr Genet        ISSN: 2146-460X


  34 in total

1.  TPMT genotype and its clinical implication in renal transplant recipients with azathioprine treatment.

Authors:  D-K Song; J Zhao; L-R Zhang
Journal:  J Clin Pharm Ther       Date:  2006-12       Impact factor: 2.512

2.  Precision therapy of 6-mercaptopurine in Chinese children with acute lymphoblastic leukaemia.

Authors:  Yue Zhou; Li Wang; Xiao-Ying Zhai; Li Wen; Fang Tang; Fan Yang; Xi-Ting Liu; Lei Dong; Li-Juan Zhi; Hai-Yan Shi; Guo-Xiang Hao; Yi Zheng; Evelyne Jacqz-Aigrain; Tian-You Wang; Wei Zhao
Journal:  Br J Clin Pharmacol       Date:  2020-03-03       Impact factor: 4.335

3.  Multidrug resistance protein 4 (MRP4) polymorphisms impact the 6-mercaptopurine dose tolerance during maintenance therapy in Japanese childhood acute lymphoblastic leukemia.

Authors:  Y Tanaka; A Manabe; H Fukushima; R Suzuki; H Nakadate; K Kondoh; K Nakamura; K Koh; T Fukushima; M Tsuchida; K Koike; N Kiyokawa; E Noguchi; R Sumazaki; T Komiyama
Journal:  Pharmacogenomics J       Date:  2014-11-18       Impact factor: 3.550

4.  Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update.

Authors:  Mary V Relling; Matthias Schwab; Michelle Whirl-Carrillo; Guilherme Suarez-Kurtz; Ching-Hon Pui; Charles M Stein; Ann M Moyer; William E Evans; Teri E Klein; Federico Guillermo Antillon-Klussmann; Kelly E Caudle; Motohiro Kato; Allen E J Yeoh; Kjeld Schmiegelow; Jun J Yang
Journal:  Clin Pharmacol Ther       Date:  2019-01-20       Impact factor: 6.875

5.  Outcome of Childhood Acute Lymphoblastic Leukemia Treated Using the Thai National Protocols.

Authors:  Panya Seksarn; Surapon Wiangnon; Gavivann Veerakul; Thirachit Chotsampancharoen; Somjai Kanjanapongkul; Su-On Chainansamit
Journal:  Asian Pac J Cancer Prev       Date:  2015

6.  Effect of NUDT15 on incidence of neutropenia in children with acute lymphoblastic leukemia.

Authors:  Jassada Buaboonnam; Pariwan Sripatanatadasakul; Ajjima Treesucon; Waraporn Glomglao; Preeyanun Siraprapapat; Nattee Narkbunnam; Nassawee Vathana; Chayamon Takpradit; Kamon Phuakpet; Bunchoo Pongtanakul; Sasima Tongsai; Phakatip Sinlapamongkolkul; Kleebsabai Sanpakit
Journal:  Pediatr Int       Date:  2019-08-14       Impact factor: 1.524

7.  Thiopurine S-methyltransferase (TPMT) polymorphisms in children with acute lymphoblastic leukemia, and the need for reduction or cessation of 6-mercaptopurine doses during maintenance therapy: the Polish multicenter analysis.

Authors:  Jarosław Peregud-Pogorzelski; Edyta Tetera-Rudnicka; Mateusz Kurzawski; Andrzej Brodkiewicz; Natalia Adrianowska; Wojciech Mlynarski; Danuta Januszkiewicz; Marek Drozdzik
Journal:  Pediatr Blood Cancer       Date:  2011-02-11       Impact factor: 3.167

8.  A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia.

Authors:  Suk-Kyun Yang; Myunghee Hong; Jiwon Baek; Hyunchul Choi; Wanting Zhao; Yusun Jung; Talin Haritunians; Byong Duk Ye; Kyung-Jo Kim; Sang Hyoung Park; Soo-Kyung Park; Dong-Hoon Yang; Marla Dubinsky; Inchul Lee; Dermot P B McGovern; Jianjun Liu; Kyuyoung Song
Journal:  Nat Genet       Date:  2014-08-10       Impact factor: 38.330

9.  Genes implicated in thiopurine-induced toxicity: Comparing TPMT enzyme activity with clinical phenotype and exome data in a paediatric IBD cohort.

Authors:  Tracy Coelho; Gaia Andreoletti; James J Ashton; Akshay Batra; Nadeem Ahmad Afzal; Yifang Gao; Anthony P Williams; Robert M Beattie; Sarah Ennis
Journal:  Sci Rep       Date:  2016-10-05       Impact factor: 4.379

10.  Star Allele-Based Haplotyping versus Gene-Wise Variant Burden Scoring for Predicting 6-Mercaptopurine Intolerance in Pediatric Acute Lymphoblastic Leukemia Patients.

Authors:  Yoomi Park; Hyery Kim; Jung Yoon Choi; Sunmin Yun; Byung-Joo Min; Myung-Eui Seo; Ho Joon Im; Hyoung Jin Kang; Ju Han Kim
Journal:  Front Pharmacol       Date:  2019-06-11       Impact factor: 5.810

View more
  1 in total

Review 1.  Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations.

Authors:  Kanyarat Khaeso; Sariya Udayachalerm; Patcharee Komvilaisak; Su-On Chainansamit; Kunanya Suwannaying; Napat Laoaroon; Pitchayanan Kuwatjanakul; Nontaya Nakkam; Chonlaphat Sukasem; Apichaya Puangpetch; Wichittra Tassaneeyakul; Nathorn Chaiyakunapruk
Journal:  Front Pharmacol       Date:  2021-12-02       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.